The 45th San Antonio Breast Cancer Symposium will host 10,000 clinicians and scientists from all over the world and is the largest and most prestigious scientific gathering on breast cancer research. This international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. VJOncology will be in attendance to help disseminate the latest learnings from the meeting.
View all videos

SABCS 2022

San Antonio Breast Cancer Symposium 2022
06–10 December 2022 | San Antonio, TX
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @changhoon_yoo of @AsanMedicalCtr talks on the impact of immunotherapy and checkpoint inhibition in treating HCC

Watch: 👉http://ow.ly/ispZ50MINVh👈

@ASCO #GI23 #GastrointestinalCancer #HPBCSM

Reply on Twitter 1621916812106407937Retweet on Twitter 1621916812106407937Like on Twitter 1621916812106407937Twitter 1621916812106407937
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🌎 Today marks #WorldCancerDay2023, and visit our website at http://VJOncology.com as we continue to update you on the latest in #oncology with exclusive interviews, insightful sessions, and more!

#BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm @uicc

Reply on Twitter 1621856377676120065Retweet on Twitter 1621856377676120065Like on Twitter 16218563776761200651Twitter 1621856377676120065
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

This week's podcast is an overview of updates in biliary tract cancer at ASCO GI with Ghassan Abou-Alfa (@GABOUALFA).

Listen here: 🎧 http://ow.ly/TP8a50MIWeg 🎧

#HPBCSM #GastrointestinalCancer @ASCO #GI23

Reply on Twitter 1621841373975429120Retweet on Twitter 1621841373975429120Like on Twitter 1621841373975429120Twitter 1621841373975429120
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @adasarimd of @MDAndersonNews discusses updates from the CIRCULATE-US trial

Watch: 👉http://ow.ly/PYMe50MINTU👈

@ASCO #GI23 #GastrointestinalCancer #CRCSM #ColorectalCancer

Reply on Twitter 1621795899356725248Retweet on Twitter 1621795899356725248Like on Twitter 16217958993567252481Twitter 1621795899356725248
VJOncologyVJ Oncology@VJOncology·
February 3, 2023

🎥 @NataliyaUboha of @UWCarbone talks on targeting CLDN18.2 with zolbetuximab in gastric and GEJ cancer

Watch: 👉http://ow.ly/JnFx50MINSY👈

@ASCO #GI23 #GastrointestinalCancer #GastricCancer #STCSM #ESOCSM

Reply on Twitter 1621554647004585986Retweet on Twitter 1621554647004585986Like on Twitter 1621554647004585986Twitter 1621554647004585986
Load More

SABCS 2022

San Antonio Breast Cancer Symposium 2022
06–10 December 2022 | San Antonio, TX
The 45th San Antonio Breast Cancer Symposium will host 10,000 clinicians and scientists from all over the world and is the largest and most prestigious scientific gathering on breast cancer research. This international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. VJOncology will be in attendance to help disseminate the latest learnings from the meeting.
View all videos
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @changhoon_yoo of @AsanMedicalCtr talks on the impact of immunotherapy and checkpoint inhibition in treating HCC

Watch: 👉http://ow.ly/ispZ50MINVh👈

@ASCO #GI23 #GastrointestinalCancer #HPBCSM

Reply on Twitter 1621916812106407937Retweet on Twitter 1621916812106407937Like on Twitter 1621916812106407937Twitter 1621916812106407937
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🌎 Today marks #WorldCancerDay2023, and visit our website at http://VJOncology.com as we continue to update you on the latest in #oncology with exclusive interviews, insightful sessions, and more!

#BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm @uicc

Reply on Twitter 1621856377676120065Retweet on Twitter 1621856377676120065Like on Twitter 16218563776761200651Twitter 1621856377676120065
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

This week's podcast is an overview of updates in biliary tract cancer at ASCO GI with Ghassan Abou-Alfa (@GABOUALFA).

Listen here: 🎧 http://ow.ly/TP8a50MIWeg 🎧

#HPBCSM #GastrointestinalCancer @ASCO #GI23

Reply on Twitter 1621841373975429120Retweet on Twitter 1621841373975429120Like on Twitter 1621841373975429120Twitter 1621841373975429120
VJOncologyVJ Oncology@VJOncology·
February 4, 2023

🎥 @adasarimd of @MDAndersonNews discusses updates from the CIRCULATE-US trial

Watch: 👉http://ow.ly/PYMe50MINTU👈

@ASCO #GI23 #GastrointestinalCancer #CRCSM #ColorectalCancer

Reply on Twitter 1621795899356725248Retweet on Twitter 1621795899356725248Like on Twitter 16217958993567252481Twitter 1621795899356725248
VJOncologyVJ Oncology@VJOncology·
February 3, 2023

🎥 @NataliyaUboha of @UWCarbone talks on targeting CLDN18.2 with zolbetuximab in gastric and GEJ cancer

Watch: 👉http://ow.ly/JnFx50MINSY👈

@ASCO #GI23 #GastrointestinalCancer #GastricCancer #STCSM #ESOCSM

Reply on Twitter 1621554647004585986Retweet on Twitter 1621554647004585986Like on Twitter 1621554647004585986Twitter 1621554647004585986
Load More
HR+ HER2-low HER2+ TNBC

Watch the latest videos from SABCS 2022!

View all
1:12
Remaining questions on the use of frontline CDK4/6 inhibitors + endocrine therapy
Sibylle Loibl • 6 Dec 2022
0:48
What to look forward to at SABCS 2022
Andrea De Censi • 6 Dec 2022
1:13
TAM-01: low-dose tamoxifen in women with breast intraepithelial neoplasia
Andrea De Censi • 6 Dec 2022
1:06
SABCS 2022 highlights
Adam Brufsky • 6 Dec 2022

VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals